Digital PCR (dPCR) provides precise and absolute quantification of nucleic acids without a standard curve and without dependence on amplification efficiency. It is ultrasensitive; therefore, appropriate for testing allelic variants and targets of low abundance that are below the sensitivity limit of QPCR. It is also very precise, and is a better tool than QPCR when precise determination of the ratio of several nucleic acid sequences is required.
Read More →
Avance Biosciences can perform a broad range qPCR assays using TaqMan® probes, meeting research grade or GLP/GMP compliance. Customers can select established real-time qPCR assays from Avance Biosciences’ assay list or from the Applied Biosystems website. Assay development, including assay design and validation, is also available.
Read More →Avance Biosciences offers a broad range of QPCR Assay Development services, including assay design, assay validation, sample testing, and technology transfer under GLP compliance to support drug research and development.
Read More →
In vivo Biodistribution studies are required by regulatory agencies to evaluate the safety and toxicity of gene therapy vectors. Avance Biosciences offers GLP compliant QPCR services to accurately assess the quantity of gene therapy vectors in target and non-target tissues.
Read More →QPCR is a “Gold Standard” tool that is widely used to determine DNA quantity in biological samples. Avance Biosciences offers a broad range of QPCR services, including assay design, assay validation, sample testing, and technology transfer under GLP compliance to support drug research and development.
Read More →